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TCT-544
The Safety and Feasibility of Sheathless Transradial Carotid Artery Stenting
(Comparing with Transbrachial Carotid Artery Stenting)
Hsiu-Yu Fang, Chiung-Jen Wu
Division of Cardiology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung
City, Taiwan
Background: Our pilot study had already evaluated the feasibility and safety of TRA
and TBA CAS using Catheter Looping And Retrograde Engagement Technique
(CLARET). The major limitation of TRA CAS is the inability to use large guiding
catheters (7Fr.) when radial artery size is too small. Before the sheathless technique,
we used TBA instead of TRA.
Methods: 33 patients with documented carotid artery stenosis and smaller radial artery,
whom were selected for CAS via sheathless TRA, and comparing with 61 patients
underwent CAS using TBA. Usual radial puncture with a 5Fr. sheath was introduced,
and 5Fr. Ikari-Lt 3.5 guiding was used for diagnostic cerebral angiography, and
changed to 7F Kimny-Rad guide via sheathless manner for CAS. Routine assessment
of radial artery patency was made either by Doppler or reverse Allen’s test at 1 month
(mo) and 6-mo after CAS.
Results: This sheathless TRA CAS technique offered 100% diagnostic and procedure
success. There were no baseline characteristics differences between TRA and TBA.
Only one patient (3.1%) experienced transient ischemia attack (TIA) during the
procedure and immediately recovery during hospitalization. There were no major
complications (major stroke or 30 day in-hospital death), or radial access site
complications (compartment syndrome, or acute blood loss need blood transfusion),
as compared with TBA CAS, composite end points occurred in 3/61 (4.9%) (one major
stroke and two pseudo-aneurysm required surgical repair). Mean hospital stay in TBA
was longer than TRA (10.9 ± 8.4 v.s. 8.3 ± 5.5 days, p=0.042). All radial arteries were
patent after CAS during 1-mo and 6-mo clinical follow-up.
Conclusion: The results showed that sheathless TRA CAS in patients with smaller
radial artery, is safe and technically feasible with acceptable low complications with
shorter hospital stay, Long-term radial patency was achieved at follow-up (6-mo) after
TRA CAS.
TCT-545
Carotid artery stenting in patients with and without contralateral stenosis (≥
50%)
Alexander Kypta, Clemens Steinwender, Klaus Kerschner, Robert Hofmann, Michael
Grund, Franz Leisch
General and University Teaching Hospital Linz Cardiovascular Division, Linz,
Austria
Background: The goal of this study was to evaluate the clinical and sonographic
outcome of patient undergoing carotid artery stenting (CAS) with and without
contralateral stenosis of (≥ 50%).
Methods: This retrospective study included 1035 patients (335 female/700 male, mean
age 70±9 years) undergoing percutaneous transluminal angioplasty and stenting of
CAS. The indications for CAS were symptomatic patients with a stenosis ≥60% or
asymptomatic patients with a stenosis ≥80%.There were 188 patients with contralateral
stenosis (CS) of ≥50% and 847 without (NoCS). Adverse events were defined as death,
stroke (≥24 hours), PRIND (≤72 hours). We compared the risk of procedural and long-
term adverse events (≥6 months) after the CAS. Binary instent restenosis was defined
by Doppler ultrasound with a restenosis of ≥50%.
Results: Technical success was achieved in 186 patients with CS (98.9%) and in 823
patients with NoCS (97.2%). A filter wire (Boston Scientific) was used in 51% of the
CS patients and in 56% of the NoCS patients (p<0.05).The risk of procedural adverse
events was 3.2% in the CS group and 2.8% in the NoCS group (p=ns). During a mean
follow-up period of 36 ± 6 months, asymptomatic binary instent restenosis occured in
22 (11.7%) of the CS patients, and in 50 (5.9%) of the NoCS patients (p<0.005). There
were 41 (21.8%) deaths (3 cerebral, 26 cardiac, 12 other) in the CS group and 184
(21.7%) in the NoCS group (15 cerebral, 92 cardiac, 77 other; p=ns).
Conclusion: CAS is feasible, safe and shows comparable procedural outcomes in
patients with or without contralateral stenosis. During long-term follow-up (36 months)
binary instent restenosis occurs significantly more frequent in patients with CS (11.7%)
than in patients with NoCS (5.9%) group (p<0.005).
TCT-546
Novel predictors for in-stent restenosis (ISR) after carotid artery stenting (CAS)
Roland Richard Macharzina, Christian Claus, Janine Schiek, Tanja Böhme, Aljosha
Rastan, Nian Fan, Uli Beschorner, Sebastian Sixt, Franz-Joseph Neumann, Thomas
Zeller
Angiology, Heart Center Bad Krozingen, Bad Krozingen, Germany
Background: ISR after CAS is a determinant of outcome. Knowledge about predictors
of ISR may contribute to improved patient selection. A prospective single-center CAS-
registry (KrozCar) was analysed regarding risc factors, stenosis-morphology,
neurological- as well as procedure-related variables to find predictors for ISR. We
hypothesized, that short- to mid-term ISR may be associated with independent
predictors.
Methods: 375 consecutive patients (pts), 282 men and 93 women were analysed.
Progression of disease was monitored at day 3, 30, 180 and 360 after CAS by duplex
ultrasound (DUS). Pts were seen by a neurologist before and after the procedure.
Restenosis was assessed by using standardized DUS criteria for identification of ≥50%
NASCET carotid stenosis. In case of contralateral occlusion, internal- to common
carotid peak velocity-ratio was used for grading at follow-up (FU). B-mode ultrasound
was used to determine plaque morphology prospectively. CAS was performed by a
single interventionalist. CAS technique was adapted to pertinent developments
regarding stents, protection devices and product performance within 12 years of
inclusion. Uni- and multivariate analyses were used for identification of independent
predictors for ISR. Statistics was with SPSS.
Results: 322 pts. completed clinical FU (86%). Post-hoc analysis of DUS prospective
pictorial online documentation was in 188 pts at 12 months. ISR rate was 9,1% (n=34)
in total at 12 months: 5,3% for 50-69% and 3,7% for >70% stenosis. Neurological
event was observed only once after occurrence of ISR. Univariate analysis of all
variables showed that calcified plaque (OR 4,73; P=0,003), shorter plaque-length (OR
3,45; P=0,018) and contralateral occlusion (OR 2,67; P=0,031) were associated with
ISR. On multivariate regression analysis all of these factors turned out to be
independent predictors for isr.
Conclusion: New independent predictors of ISR were found by detailed analysis of
ultrasound images in a cohort with moderate incidence of ISR. The results of this study
may be worth to be analysed in a large multicenter trial.
TCT-547
Transcatheter Laser Revascularization of Brain Vessels in the Treatment of
Vascular Dementia
Ivan V. Maksimovich
Clinic of Cardiovascular Diseases named after Most Holy John Tobolsky, Moscow,
Russian Federation
Background: The number of patients with cerebral vessels atherosclerosis is growing
around the world. The research purpose is the study of brain transcatheter laser
revascularization efficacy in the treatment of cerebral atherosclerosis accompanied by
vascular dementia.
Methods: The investigation included 665 patients 478 (71.87%) men, 187 (28.13%)
women aged 40-81 (average age 75) suffering from various types of atherosclerotic
lesions of brain vessels accompanied by vascular dementia. All the patients underwent
CT, MRI, SG, REG, MUGA. 639 (96.09%) patients underwent transcatheter treatment
revealing the following: 86 patients had macrofocal strokes, 74 medium focal strokes,
29 single microfocal strokes, 36 multiple microfocal strokes, 273 patients had
atherosclerotic lesions without strokes, 98 had arteriolosclerosis, 37 had atherosclerotic
parkinsonism, 6 had Binswanger’s disease. Of these, CDR-1 - 352 (55.09%), CDR-2
- 184 (28.79%), CDR-3 - 103 (16.12%) patients. For revascularization of main
intracranial arteries high-energy laser systems were used; for revascularization of distal
intracranial branches low-energy laser systems were used.
Results: A good immediate angiographic result manifested in the restoration of
vascular lumen and patency as well as collateral revascularization was achieved in 628
(98.27%) cases. Clinical results were dependent on the severity of ischemic lesion,
atherosclerosis spread, the severity of dementia and the timing of surgical intervention.
Good clinical result (Index Bartels-IB-100) in group CDR-1 was achieved in 282
(80.11%), CDR-2 in 81 (44.02%), CDR-3 in 9 (8.73%) cases. Satisfactory clinical
result (IB-70-80) in group CDR-1 was obtained in 53 (15.06%), CDR-2 in 62 (33.70%),
CDR-3 in 31 (30.09%) cases. Relatively satisfactory clinical result (IB-50-60) in CDR-
1 was obtained in 17 (4.83%), CDR-2 in 41 (22.28%), CDR-3 in 63 (61.16%) cases.
Conclusion: Evaluating the data obtained we can conclude that the method of
transcatheter laser revascularization of cerebral blood vessels is an effective one in the
treatment of atherosclerotic lesions of the brain accompanied by dementia.
TCT-548
Outcomes of Modern Endovascular Treatment of vein of Galen Malformations
in the Neonatal Period
Alejandro Berenstein
1Endovascular Neurosurgery, Roosevelt Hospital, New York, NY; 2Roosevelt
Hospital, New York, NY
Background: Untreated patients with neonatal presentation of vein of Galen
aneurismal malformations (AMVG) carry almost 100% morbidity and mortality,
usually from uncontrollable heart failure. We report our most recent patients requiring
neonatal interventional endovascular treatment.
Methods: A consecutive series of 16 neonatal patients presented with AMVG from
2005 to 2011. Nine were treated in the newborn period by transarterial liquid
embolization with cyanoacrylate tissue adhesive (NBCA) targeting the fistula sites via
percutaneous femoral artery access. The goal was to make their heart failure medically
manageable by reducing arteriovenous shunting. Patients returned for further
endovascular treatment at 6 to 9 months of age.
Results: Neonatal control of cardiac failure was achieved in 8/9 patients. One 1.5 kg.
premature baby expired after treatment due to diffuse intracranial hemorrhage. One
patient experienced a stroke and mild hemiparesis from a microcatheter rupture. 3/9
patients demonstrated post treatment asymptomatic intracranial hemorrhage.
Angiographic cure was documented at an average age of 23 months in 6/9 patients
after an average of 2.5 treatments. 5/6 of these patients have achieved normal
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